Sinopharm Hyundai announced that Sinopharm's holding subsidiary Sinopharm Zhijun Pingshan previously signed a “Drug Marketing License Transfer Contract” with Anhui Meilai, and recently received the “Drug Supplement Application Approval Notice” approved and issued by the State Drug Administration, agreeing to change the marketing license holder for lactulose oral solution to Sinopharm Zhi Junping Shan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.